• 
  • Press Releases
  • About Us
    • Executive Management
    • Board of Directors
    • Palatin Scientific Advisors
    • Careers at Palatin
    • Corporate Governance
      • Reporting Hotline
  • Vyleesi
  • Research Focus
    • Clinical Pipeline
    • Our Focus: Peptide Drugs
    • Ocular Indications
    • PL8177 for Inflammatory Bowel Disease
    • PL8177 for COVID-19
    • Obesity and Diabetes
    • Cardiovascular Diseases
    • Licensing & Collaboration
  • Investors
    • Overview
    • Press Releases
    • Event Calendar
    • Webcasts
    • SEC Filings
    • Analyst Coverage
    • Investor Resources
  • Resources
    • Corporate Presentation
    • Vyleesi® (bremelanotide) for Hypoactive Sexual Desire Disorder (HSDD)
    • Poster Presentations
    • Scientific Publications
    • Patent Portfolio
    • Helpful Links
  • Contact Us
    • Contacting Palatin
  • Drug therapies activating the power of your body

    Palatin Technologies develops peptide therapeutics for diseases with significant unmet medical need and commercial potential.

    Learn More

    Female Sexual Dysfunction

    Vyleesi is an on-demand treatment for the most common type of female sexual dysfunction.

    Learn More

    Improving quality of life for patients with heart failure

    Natriuretic peptide mimetics for heart failure, providing increased therapeutic options.

    Learn More

    Obesity and Diabetes

    Peptide therapeutics to help regulate eating behavior and energy balance, leading to decreased food intake and weight loss.

    Learn More

    Inflammatory Diseases

    Using the melanocortin receptor-1 system to help control inflammatory and autoimmune diseases like inflammatory bowel disease, nephritis and uveitis.

    Learn More
    
    
    • Palatin Technologies, Inc.
    • Female Sexual Dysfunction
    • Heart Failure
    • Obesity and Diabetes
    • Inflammatory Diseases

    Pipeline

    Pipeline

    Status of our clinical and preclinical programs, including our inflammatory and heart disease programs.

    Learn More

    Investors

    Investors

    Learn about Palatin, including press releases, presentations, filings with the Securities and Exchange Commission and more.

    Learn More

    News

    News

    The latest news about Palatin, with the full text of press releases issued by Palatin.

    Learn More

    Upcoming Events

    Upcoming Events

    Scheduled presentations by Palatin senior management, quarterly calls, scientific presentations and other upcoming events.

     

    Learn More

    Corporate Presentation

    Corporate Presentation

    Palatin’s corporate presentation, with an emphasis on Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD), and other pipeline development programs.

    Learn More
    • © 2020 Palatin Technologies, Inc. All rights reserved.
    • Privacy Policy
    • Terms of Use
    • Contact Us
    • Sitemap